☰

Wim van den Brink, Ph.D. M.D.

Affiliations: 
Psychiatry Academic Medical Center Amsterdam, Amsterdam, Netherlands 
Area:
Addiction
Website:
https://www.amc.nl/web/research/who-is-who-in-research/who-is-who-in-research.htm?p=384
Google:
"Wim van den Brink"
Bio:

http://www.lebic-amc.nl/research-groups/wim-van-den-brink
Prof. dr. W. van den Brink at the Album Academicum of the University of Amsterdam
http://irs.ub.rug.nl/ppn/055787258
http://alba.ub.rug.nl/promotorum/?page=showPerson&promovendus_id=3740

Mean distance: 16.75 (cluster 48)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Rob Giel grad student 1989 RUG
 (Meting van DSM-III persoonlijkheidspathologie: betrouwbaarheid en validiteit van de SIDP-R en as II van de DSM-III)

Children

Sign in to add trainee
Cleo Crunelle grad student AMC Amsterdam
Jochem Jansen grad student AMC Amsterdam
Anne-Marije Kaag grad student AMC Amsterdam
Judy Luigjes grad student AMC Amsterdam
Lianne Schmaal grad student AMC Amsterdam
Elsmarieke Van de Giessen grad student AMC Amsterdam
Ruth Van Holst grad student AMC Amsterdam
Eline Zaaijer grad student AMC Amsterdam
Zsuzsika Sjoerds grad student 2008-2012 AMC Amsterdam
Anneke E. Goudriaan post-doc AMC Amsterdam

Collaborators

Sign in to add collaborator
Jan Booij collaborator AMC Amsterdam
Damiaan Denys collaborator AMC Amsterdam
Brenda W.J.H. Penninx collaborator VUmc
Dick J. Veltman collaborator Academic Medical Center
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Migchels C, Zerrouk A, Crunelle CL, et al. (2023) Patient Reported Outcome and Experience Measures (PROMs and PREMs) in substance use disorder treatment services: A scoping review. Drug and Alcohol Dependence. 253: 111017
Brynte C, Aeschlimann M, Barta C, et al. (2022) The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study. Bmc Psychiatry. 22: 625
Özgen H, Spijkerman R, Noack M, et al. (2021) [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie
Pape L, van Lith K, Veltman D, et al. (2021) Effect of Methylphenidate on Resting-State Connectivity in Adolescents With a Disruptive Behavior Disorder: A Double-Blind Randomized Placebo-Controlled fMRI Study. Frontiers in Psychiatry. 12: 662652
Marees AT, Smit DJA, Abdellaoui A, et al. (2021) Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits. Nature Human Behaviour
Abdellaoui A, Smit DJA, van den Brink W, et al. (2021) Genomic relationships across psychiatric disorders including substance use disorders. Drug and Alcohol Dependence. 220: 108535
Kapitány-Fövény M, Barta C, Crunelle CL, et al. (2020) [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder]. Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata. 35: 435-447
Özgen H, Spijkerman R, Noack M, et al. (2020) International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. European Addiction Research. 1-10
Schellekens AFA, van den Brink W, Kiefer F, et al. (2020) Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction - Addiction in ADHD. European Addiction Research. 1-4
Van de Glind G, Brynte C, Skutle A, et al. (2020) The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities. European Addiction Research. 1-6
See more...